Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-143245
Filing Date
2025-06-20
Accepted
2025-06-20 08:11:22
Documents
12
Effectiveness Date
2025-06-20

Document Format Files

Seq Description Document Type Size
1 S-8 d21623ds8.htm S-8 76777
2 EX-4.5 d21623dex45.htm EX-4.5 122849
3 EX-4.6 d21623dex46.htm EX-4.6 58653
4 EX-4.7 d21623dex47.htm EX-4.7 45010
5 EX-4.8 d21623dex48.htm EX-4.8 53351
6 EX-4.9 d21623dex49.htm EX-4.9 112069
7 EX-4.10 d21623dex410.htm EX-4.10 54179
8 EX-4.11 d21623dex411.htm EX-4.11 45190
9 EX-5.1 d21623dex51.htm EX-5.1 9053
10 EX-23.1 d21623dex231.htm EX-23.1 2330
11 EX-FILING FEES d21623dexfilingfees.htm EX-FILING FEES 33772
12 GRAPHIC g21623g0613030534197.jpg GRAPHIC 2534
  Complete submission text file 0001193125-25-143245.txt   618002
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288169 | Film No.: 251059142
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)